July 5th, 2022 Ubiquigent appoints Professor Helen Walden and Professor John Davis to Scientific Advisory Board
December 14th, 2021 Ubiquigent celebrates milestone anniversary of DUBprofiler™ compound profiling platform
December 14th, 2021 Ubiquigent celebrates milestone anniversary of DUBprofiler™ compound profiling platform
October 26th, 2021 Ubiquigent Extends and Expands Drug Discovery Collaboration with Bristol Myers Squibb